Cellebrite DI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	2,199	1,659	799	1,445	790
Market Cap Growth	-	107.61%	-44.70%	82.97%	-
Enterprise Value	1,931	1,370	631	1,263	547
PE Ratio	-20.46	-20.46	6.88	20.52	-84.52
PS Ratio	6.83	5.10	2.95	5.87	4.05
PB Ratio	64.90	48.49	10.82	-19.70	12.38
P/FCF Ratio	23.58	17.62	69.53	51.71	13.09
P/OCF Ratio	21.76	16.26	38.83	40.08	11.87
EV/Sales Ratio	5.94	4.21	2.33	5.13	2.81
EV/EBITDA Ratio	44.66	31.68	113.78	63.60	-19534.86
EV/EBIT Ratio	58.11	41.22	-172.83	98.25	-92.60
EV/FCF Ratio	20.52	14.55	54.89	45.22	9.07
Debt / Equity Ratio	0.41	0.41	0.21	-	-
Debt / EBITDA Ratio	0.33	0.33	2.77	-	-
Debt / FCF Ratio	0.15	0.15	1.34	-	-
Quick Ratio	1.50	1.50	1.26	1.33	1.94
Current Ratio	1.66	1.66	1.42	1.46	2.04
Asset Turnover	0.70	0.70	0.77	0.70	0.61
Interest Coverage	0.31	0.31	-	-	-
Return on Equity (ROE)	-251.30%	-251.30%	319.90%	-1476.10%	-15.20%
Return on Assets (ROA)	-17.60%	-17.60%	33.10%	20.00%	-2.90%
Return on Capital (ROIC)	68.76%	68.76%	1.17%	-16.32%	14.45%
Earnings Yield	-3.65%	-4.89%	14.53%	4.87%	-1.18%
FCF Yield	4.24%	5.67%	1.44%	1.93%	7.64%
Buyback Yield / Dilution	2.68%	2.68%	-20.96%	-30.59%	-1.76%
Total Shareholder Return	2.68%	2.68%	-20.96%	-30.59%	-1.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).